FIELD: biotechnology.
SUBSTANCE: present invention relates to the field of biotechnology, specifically to mimetic peptide of an apolipoprotein A-I epitope, and can be used in medicine. Mimetic peptide of the apolipoprotein A-I epitope, specifically binding to antibodies against apolipoprotein A-I, is used in a diagnostic immunoassay and allows to diagnose a number of cardiovascular diseases in a biological fluid sample.
EFFECT: mimetic peptide of the apolipoprotein A-I epitope can be used in a method for treating such cardiovascular diseases.
26 cl, 9 dwg, 3 tbl, 6 ex
Title | Year | Author | Number |
---|---|---|---|
APOPTOSIS INHIBITORS AND USE THEREOF | 2011 |
|
RU2582247C2 |
RECOMBINANT ADEN-ASSOCIATED VIRUS, WHICH IS HYBRID OF AAV9 AND AAVrh74 SEROTYPES, WITH REDUCED TROPISM FOR LIVER TISSUE | 2019 |
|
RU2812279C2 |
COMPOSITION FOR PREVENTING AND/OR TREATING INFECTION, CAUSED BY HIV-1 | 2012 |
|
RU2603262C2 |
PEPTIDES OF DIRECTED ACTION OF VEGFR-1/NRP-1 | 2008 |
|
RU2488592C2 |
ANTIBODIES SPECIFIC TO BTN2 AND THEIR APPLICATIONS | 2018 |
|
RU2794996C2 |
COMPOSITIONS RELATED TO CLOSTRIDIUM DIFFICILE MUTANT TOXIN, AND METHODS OF APPLICATION THEREOF | 2012 |
|
RU2592686C2 |
NOVEL CELL-PENETRATING PEPTIDES | 2013 |
|
RU2670488C2 |
CONJUGATES FOR ADMINISTERING BIOLOGICALLY ACTIVE COMPOUNDS | 2009 |
|
RU2567667C2 |
MODIFIED EXOTOXIN A PSEUDOMONADES | 2014 |
|
RU2687143C2 |
NOVEL BNP (1-32) EPITOPE AND ANTIBODIES DIRECTED AGAINST SAID EPITOPE | 2008 |
|
RU2511033C2 |
Authors
Dates
2018-07-31—Published
2013-11-06—Filed